home / stock / mycof / mycof quote
Last: | $0.08596 |
---|---|
Change Percent: | 6.77% |
Open: | $0.0807 |
Close: | $0.08596 |
High: | $0.08596 |
Low: | $0.0807 |
Volume: | 509 |
Last Trade Date Time: | 12/01/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.08596 | $0.0807 | $0.08596 | $0.08596 | $0.0807 | 509 | 12-01-2023 |
$0.08656 | $0.08656 | $0.08656 | $0.08656 | $0.08656 | 225 | 11-30-2023 |
$0.08656 | $0.0834 | $0.08656 | $0.08656 | $0.051986 | 2,129 | 11-29-2023 |
$0.07777 | $0.0514 | $0.07777 | $0.07777 | $0.0514 | 6,853 | 11-28-2023 |
$0.086339 | $0.086339 | $0.086339 | $0.086339 | $0.086339 | 5,696 | 11-27-2023 |
$0.08656 | $0.0514 | $0.08656 | $0.08656 | $0.0514 | 2,780 | 11-24-2023 |
$0.0807 | $0.0807 | $0.0807 | $0.0807 | $0.0807 | 1,717 | 11-23-2023 |
$0.0807 | $0.0807 | $0.0807 | $0.0807 | $0.0807 | 1,717 | 11-22-2023 |
$0.0807 | $0.08656 | $0.0807 | $0.09 | $0.0807 | 1,342 | 11-21-2023 |
$0.08656 | $0.08656 | $0.08656 | $0.08656 | $0.08656 | 4,159 | 11-20-2023 |
$0.091 | $0.091 | $0.091 | $0.091 | $0.091 | 2,583 | 11-17-2023 |
$0.09 | $0 | $0.09 | $0 | $0 | 75 | 11-16-2023 |
$0.09 | $0.0938 | $0.09 | $0.0938 | $0.0807 | 10,206 | 11-15-2023 |
$0.0807 | $0.0807 | $0.0807 | $0.0807 | $0.0807 | 1,109 | 11-14-2023 |
$0.051986 | $0.0514 | $0.051986 | $0.0893 | $0.0514 | 1,728 | 11-13-2023 |
$0.0892 | $0.0884 | $0.0892 | $0.0892 | $0.0884 | 422 | 11-10-2023 |
$0.05433 | $0.0807 | $0.05433 | $0.0807 | $0.05433 | 398 | 11-09-2023 |
$0.0807 | $0.0807 | $0.0807 | $0.0807 | $0.0807 | 387 | 11-08-2023 |
$0.1068 | $0.0514 | $0.1068 | $0.1068 | $0.0514 | 21,748 | 11-07-2023 |
$0.052038 | $0.1048 | $0.052038 | $0.1048 | $0.052038 | 970 | 11-06-2023 |
News, Short Squeeze, Breakout and More Instantly...
New Age Brands Company Name:
MYCOF Stock Symbol:
OTCMKTS Market:
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) , a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and post-traumatic stress disorder, has announced clarific...
DENVER, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental ...
Mydecine Innovations (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) , a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD, has filed a shelf prospectus supplement to...